Europe / Aspen's Region Head Talks Anaesthesia, COVID-19 & Organisational Transformation
Aspen’s European Head Thomas Kerscher explains how the sale of the company’s thrombosis portfolio to Mylan has…
Aspen
Last updated: 13.02.2014
Address: 98 Armstrong Avenue
La Lucia Ridge
Durban
4019,South Africa
Tel: +27 31 5808600
Web: http://www.aspenpharma.com/
Company description
South African-based JSE Limited listed Aspen is a supplier of branded and generic pharmaceuticals in approximately 100 countries across the globe and of consumer and nutritional products in selected territories.
Aspen is represented in South Africa, Australia, Hong Kong, Kenya, Tanzania, Uganda, Dubai, Germany, Ireland, Mauritius, Brazil, Mexico and Venezuela.
Aspen has 18 manufacturing facilities at 13 pharmaceutical manufacturing sites on five continents. Four of the sites are located in South Africa, four in Australia, and one in each of Kenya, Tanzania, Brazil, Mexico and Germany.
Products and services
Aspen is the leading supplier of generic medicines to both the private and public sectors in South Africa.
Aspen has production capabilities for a wide variety of product types including tablets, capsules, steriles, injectables, oral contraceptives, nutritional products, lyophilised vials, cytotoxics, suppositories, vials, form-filled seals, liquids, semi-solids and specialist active pharmaceutical ingredients.
Interviews
Miriam Rodriguez – General Manager, Aspen Pharmacare Iberia
Miriam Rodriguez, general manager of Aspen Pharmacare Iberia, highlights the steps she has taken to set up the…
Franck Hamalian – General Manager, Aspen France
Franck Hamalian, general manager of the French affiliate of Aspen, a specialty and branded multinational…
Interview: Wojciech Sulimierski – General Manager, Aspen Poland and CEE
Wojciech Sulimierski, general manager of Aspen Poland and CEE, discusses the opening of the regional operations in…
Interview: Alexandre França – CEO, Aspen Brazil
Alexandre França, CEO of Aspen Pharma Brazil, describes the transformation of the Brazilian organization over the…
Interview: Carlos Alberto Florez – General Manager, Aspen Colombia
Carlos Alberto Florez, newly appointed general manager of Aspen Colombia, already has a very clear view on…
Interview: Carlos Abelleyra Cordero – CEO Spanish LATAM, Aspen Labs,…
Carlos Abelleyra Cordero, CEO Spanish Latin America of Aspen Labs, describes the rapid development of Aspen’s…
Interview: Jean-Charles Rousset – Head of Aspen Sterile Operations and…
The head of Aspen sterile operations and managing director of Aspen NDB, reveals how their facility in France acts…
Interview: Samer Kassem – CEO, Aspen Global Incorporated, Mauritius
From humble beginnings to one of the largest companies in Mauritius; the CEO of Aspen Global Incorporated Mauritius…
Aspen Labs Mexico – Carlos Abelleyra Cordero, CEO Spanish LATAM
Aspen Labs wants Latin America to be the third pillar of success for the company, and is doing it in a different…
Aspen Malaysia – Andrew Ooi, Country Manager
Aspen Malaysia’s country manager details the company’s success in the country with a specific business model…
Interview: Marcelina Itchon, President & CEO, Aspen Philippines
Marcelina Itchon, President & CEO of Aspen Philippines, talks about what drives Aspen’s success, why the…
Interview: Marcelina Itchon, President & CEO, Aspen Philippines
Marcelina Itchon, President & CEO of Aspen Philippines, talks about what drives Aspen’s success, why the…
Interview: Marcelina Itchon, President & CEO, Aspen Philippines
Marcelina Itchon, President & CEO of Aspen Philippines, talks about what drives Aspen’s success, why the…
Stephen Saad, Group Chief Executive, Aspen
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as…
Interview: Peter Erlbacher, Chief Operations Officer, Spanish Latin America,…
The Aspen Group identified Latin America as a “large developing market where it can leverage its substantial…
Related
South Africa / Vaccines Made in Africa to Stay in Africa; Aspen Profits Up 21%; Adcock Ingram’s Down 3%
A roundup of the latest news from South African pharma, including Aspen’s impressive annual growth, Adcock…
Africa / Continent's Biggest Pharma Company Gets $700 million for Vaccine Manufacturing Know-How
With Africa struggling to vaccinate its populations against COVID-19, the World Bank – along with government…
South Africa / Ramaphosa Slams Big Pharma; Aspen Gets $700M for Vaccine Know-How; Adcock Ingram Takes Big COVID Profit Hit
The latest from South African pharma, including President Ramaphosa’s blunt criticism of Big Pharma, Aspen’s…
South Africa / Aspen Inks Deal to Manufacture J&J’s COVID-19 Vaccine
South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed…
Opinion / Malaria Prevention Cannot be Allowed to Stall During the COVID-19 Pandemic
As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr…
COVID-19 / Cipla to Begin Manufacturing Remdesivir in South Africa
The South African affiliate of Indian pharma firm Cipla will begin manufacturing and distribution of remdesivir, a…
News Roundup / South Africa Pharma June 2020
Below is a roundup of latest news from South Africa’s life sciences and healthcare industries, including a…
Rare Diseases in South Africa: Bridging the Gap for Inclusive Healthcare
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when…
Medical Device Segment braced for change in South Africa
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device…
Tackling South Africa’s “Intimate Healthcare” Needs
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it…
South African Clinical Trials: Turning Diversity into Opportunity
Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease…
Showcasing South African innovation
While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem…
